ATHA logo

Athira Pharma (ATHA)

Profile

Full Name

Athira Pharma, Inc.

Ticker Symbol

NASDAQ: ATHA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 18, 2020

Indexes

Not included

Website

http://www.athira.com

Employees

26

Key Details

Price

$0.34(+12.96%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.52(+18.45% YoY)

PE ratio

-

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.34
    ATHA price is $0.34

    30-Day Relative Volume

    0.34
    ATHA 30-day relative volume is 0.34

    Price Performance

    Price Most recent change

    +12.96%
    ATHA price was up +12.96% on Jul 3, 2025

    Price YTD change

    -42.08%
    ATHA price is down -42.08% since January 1st

    Price 1-year change

    -86.77%
    ATHA price is down -86.77% year-on-year

    Price 3-year change

    -89.44%
    ATHA price is down -89.44% over the past 3 years

    Price Range

    Price All-time high

    $34.79
    ATHA price is currently -99.02% below its historical high of $34.79

    Price 3-year low

    $0.22
    ATHA price is currently +54.55% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $13.27M
    ATHA market capitalization is $13.27 million

    Market cap 3-year change

    -89.1%
    ATHA market capitalization is down -89.1% over the past 3 years

    Market cap All-time high

    $1.11B
    ATHA market capitalization is currently -98.81% below its historical high of $1.11 billion

    Market cap sector rank

    20.51%
    ATHA market capitalization is higher than 20.51% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.57%
    ATHA shares outstanding is up +1.57% year-on-year

    Shares Outstanding 3-Year Change

    +3.24%
    ATHA shares outstanding is up +3.24% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.04
    ATHA beta is 1.04

    200-day SMA

    $0.43
    ATHA price is currently -21.06% below its 200-day simple moving average

    50-day SMA

    $0.29
    ATHA price is currently +15.33% above its 50-day simple moving average

    RSI

    61.34
    ATHA 14-day relative strength index is 61.34

    Volume

    0.34
    ATHA 30-day relative volume is 0.34

    ATR

    $0.03
    ATHA average true range is $0.03

    10-day Historical Volatility

    77.01%
    ATHA 10-day historical volatility is 77.01%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    ATHA annual revenue value is unknown

    Revenue Analysts estimate

    -
    ATHA annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    ATHA annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    ATHA annual revenue is unknown

    EPS

    EPS

    -$2.52
    ATHA annual earnings per share is -$2.52

    EPS Analysts estimate

    -$1.48
    ATHA annual earnings per share is currently +70.85% higher than the consensus analysts' forecast

    EPS 1-year change

    +18.45%
    ATHA annual earnings per share is up +18.45% year-on-year

    EPS Sector rank

    34.62%
    ATHA annual earnings per share is higher than 34.62% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ATHA annual gross profit value is unknown

    Gross margin

    -
    ATHA annual gross profit margin value is unknown

    Operating profit

    -$96.78M
    ATHA annual operating income is -$96.78 million

    Operating margin

    -
    ATHA annual operating profit margin value is unknown

    Net income

    -$96.94M
    ATHA annual net profit is -$96.94 million

    Net margin

    -
    ATHA annual net profit margin value is unknown

    Expenses

    Total expenses

    $96.78M
    ATHA annual total expenses is $96.78 million

    Operating expenses

    $96.78M
    ATHA annual total operating expenses is $96.78 million

    Cost of goods sold

    -
    ATHA annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $26.09M
    ATHA annual SGA is $26.09 million

    Depreciation and amortization

    $970.00K
    ATHA annual depreciation & amortization is $970.00 thousand

    Interest expense

    -
    ATHA annual interest expense value is unknown

    Income tax

    -
    ATHA annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$96.78M
    ATHA annual earnings before interest & taxes is -$96.78 million

    EBITDA

    -$95.81M
    ATHA annual EBITDA is -$95.81 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $58.78M
    ATHA annual total assets is $58.78 million

    Non current assets

    $3.94M
    ATHA annual long term assets is $3.94 million

    Current assets

    $54.84M
    ATHA annual total current assets is $54.84 million

    Cash and cash equivalents

    $48.44M
    ATHA annual cash & cash equivalents is $48.44 million

    Accounts receivable

    -
    ATHA annual accounts receivable value is unknown

    Inventory

    -
    ATHA annual inventory value is unknown

    Liabilities

    Total liabilities

    $13.94M
    ATHA annual total liabilities is $13.94 million

    Long term liabilities

    $803.00K
    ATHA annual total long term liabilities is $803.00 thousand

    Current liabilities

    $13.13M
    ATHA annual total current liabilities is $13.13 million

    Accounts payable

    $319.00K
    ATHA annual accounts payable is $319.00 thousand

    Debt

    Total debt

    $1.22M
    ATHA annual total debt is $1.22 million

    Total debt 1-year change

    -23.22%
    ATHA annual total debt is down -23.22% year-on-year

    Long term debt

    $803.00K
    ATHA annual long term debt is $803.00 thousand

    Short term debt

    $414.00K
    ATHA annual short term debt is $414.00 thousand

    Equity & Capital

    Shareholders equity

    $44.84M
    ATHA annual stockholders equity is $44.84 million

    Book value

    $44.84M
    ATHA annual book value is $44.84 million

    Retained earnings

    -$406.15M
    ATHA annual retained earnings is -$406.15 million

    Working capital

    $41.71M
    ATHA annual working capital is $41.71 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$97.17M
    ATHA annual cash flow from operations is -$97.17 million

    Cash from operations 1-year change

    +3.56%
    ATHA annual cash flow from operations is up +3.56% year-on-year

    Cash from investing

    $54.83M
    ATHA annual cash flow from investing activities is $54.83 million

    Cash from investing 1-year change

    -42.34%
    ATHA annual cash flow from investing activities is down -42.34% year-on-year

    Cash from financing

    $194.00K
    ATHA annual cash flow from financing activities is $194.00 thousand

    Cash from financing 1-year change

    -60.65%
    ATHA annual cash flow from financing activities is down -60.65% year-on-year

    CAPEX

    CAPEX

    -
    ATHA annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ATHA annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$97.20M
    ATHA annual free cash flow is -$97.20 million

    Free cash flow 1-year change

    +3.81%
    ATHA annual free cash flow is up +3.81% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ATHA annual gross profit margin value is unknown

    Operating margin

    -
    ATHA annual operating profit margin value is unknown

    Net margin

    -
    ATHA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -164.92%
    ATHA annual return on assets is -164.92%

    ROE

    -216.19%
    ATHA annual return on equity is -216.19%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ATHA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ATHA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.36
    ATHA price to book ratio is 0.36

    PB ratio Sector rank

    22.5%
    ATHA price to book ratio is higher than 22.5% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ATHA price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ATHA price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$12.03M
    ATHA enterprise value is -$12.03 million

    Enterprise value Sector rank

    3.47%
    ATHA enterprise value is higher than 3.47% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.15
    ATHA EV/EBITDA is 0.15

    EV/EBITDA Sector rank

    68.91%
    ATHA EV/EBITDA is higher than 68.91% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.18
    ATHA annual current ratio is 4.18

    Quick ratio

    -
    ATHA annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.03
    ATHA annual debt to equity ratio is 0.03

    Interest coverage ratio

    -
    ATHA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ATHA piotroski f-score value is unknown

    Altman Z-Score

    -
    ATHA altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Sep 19, 24 Mizuho
    Neutral
    Sep 4, 24 JMP Securities
    Market Perform
    Sep 4, 24 BTIG
    Neutral
    Aug 19, 24 Rodman & Renshaw
    Buy
    Jun 20, 24 JMP Securities
    Market Outperform
    May 16, 24 JMP Securities
    Market Outperform
    Aug 11, 23 JMP Securities
    Outperform
    May 15, 23 Mizuho
    Buy
    Mar 30, 23 BTIG
    Buy
    Mar 24, 23 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with ATHA included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Stocks recommended to hold
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    • What is the ticker symbol for Athira Pharma?
    • Does Athira Pharma pay dividends?
    • What sector is Athira Pharma in?
    • What industry is Athira Pharma in?
    • What country is Athira Pharma based in?
    • When did Athira Pharma go public?
    • Is Athira Pharma in the S&P 500?
    • Is Athira Pharma in the NASDAQ 100?
    • Is Athira Pharma in the Dow Jones?
    • When was Athira Pharma's last earnings report?
    • When does Athira Pharma report earnings?

    What is the ticker symbol for Athira Pharma?

    The ticker symbol for Athira Pharma is NASDAQ:ATHA

    Does Athira Pharma pay dividends?

    No, Athira Pharma does not pay dividends

    What sector is Athira Pharma in?

    Athira Pharma is in the Healthcare sector

    What industry is Athira Pharma in?

    Athira Pharma is in the Biotechnology industry

    What country is Athira Pharma based in?

    Athira Pharma is headquartered in United States

    When did Athira Pharma go public?

    Athira Pharma's initial public offering (IPO) was on September 18, 2020

    Is Athira Pharma in the S&P 500?

    No, Athira Pharma is not included in the S&P 500 index

    Is Athira Pharma in the NASDAQ 100?

    No, Athira Pharma is not included in the NASDAQ 100 index

    Is Athira Pharma in the Dow Jones?

    No, Athira Pharma is not included in the Dow Jones index

    When was Athira Pharma's last earnings report?

    Athira Pharma's most recent earnings report was on May 9, 2025

    When does Athira Pharma report earnings?

    The next expected earnings date for Athira Pharma is August 1, 2025
    On this page